ArticleScientific reports2026
Masculine depression and acute mental health burden.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interaction of serum resistin and smoking behavior in predicting depression risk: a sex-sensitive analysis.BMC psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Masculine depression is characterized by externalizing symptoms, including anger, aggression, substance use, and risk-seeking behavior. However, the understanding of its clinical presentation remains highly limited. Here, we tested mental health burden in patients with high masculine depression scores in a case-control study of 163 depressed in-patients (44% women and 56% men; high vs. low masculine depression scores according to a sex-separated median split of the Male Depression Risk Scale-22 [MDRS-22]) and 176 controls (51% women and 49% men). In models adjusted for depression severity, the group of patients with a high masculine depression score (compared to those with a low score) was related to a greater acute mental health burden as measured by the Symptom Checklist-90-Revised (SCL-90-R). This association was evident across the three global indices of the SCL-90-R. Moreover, the dimensions somatization, anger-hostility, paranoid ideation, and psychoticism were associated with the group of patients with high masculine depression scores relative to the group of patients with low masculine depression scores as well as to higher MDRS-22 scores. Here, we provide evidence that patients with high masculine depression scores experience a substantial mental health burden – regardless of their biological sex. This is important, as patients with masculine depression were shown to be undertreated.Trial registration German Clinical Trials Register ID DRKS00015291, Registration Date 2020-01-06.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.